Literature DB >> 25156101

Treatment of Stage II Adult Acquired Flatfoot Deformity With Subtalar Arthroereises.

Yuan Zhu1, Xiang-Yang Xu2.   

Abstract

UNLABELLED: The role of arthroereises in the treatment of adult acquired flatfoot deformity (AAFD) has been controversial. This study aims to evaluate the outcome of subtalar arthroereisis in treating stage II AAFD. A total of 24 feet with stage II AAFD were treated surgically between 2009 and 2011 using subtalar arthroereisis. The average follow-up was 29.7 months (range = 24 to 35 months). The average postoperative AOFAS (American Orthopaedic Foot and Ankle Society) Ankle-Hindfoot Scale score was 85.6 (compared with 51.7 preoperatively). Average preoperative talar-first metatarsal angle and talonavicular coverage angle were -13.9° and 38.3°, respectively. The average postoperative angles were 1.6° and 11.2°, respectively (P < .01). No deformity recurrences were found at the time of last follow-up, with the exception of 1 case. Subtalar arthroereisis appears to be a reasonable treatment option for stage IIA and IIC AAFD. It can be used alone to correct mild hindfoot valgus, and it can also be performed with a calcaneal osteotomy to gain more correction in severe stage II AAFD. LEVELS OF EVIDENCE: Therapeutic, Level IV: Retrospective Case Series.
© 2014 The Author(s).

Entities:  

Keywords:  flat foot; posterior tibial tendon deficiency; sinus tarsi; subtalar joint

Mesh:

Year:  2014        PMID: 25156101     DOI: 10.1177/1938640014548320

Source DB:  PubMed          Journal:  Foot Ankle Spec        ISSN: 1938-6400


  10 in total

1.  [Percutaneous calcaneal sliding osteotomy].

Authors:  M Walther; S Kriegelstein; S Altenberger; A Röser
Journal:  Oper Orthop Traumatol       Date:  2016-07-12       Impact factor: 1.154

Review 2.  A pictorial review of reconstructive foot and ankle surgery: evaluation and intervention of the flatfoot deformity.

Authors:  Andrew J Meyr; Laura E Sansosti; Sayed Ali
Journal:  J Radiol Case Rep       Date:  2017-06-30

3.  Surgical treatment of stage II posterior tibialis tendon dysfunction: ten-year clinical and radiographic results.

Authors:  Alberto Ruffilli; Francesco Traina; Sandro Giannini; Roberto Buda; Fabrizio Perna; Cesare Faldini
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-07-11

4.  Use of the arthroereisis screw with tendoscopic delivered platelet-rich plasma for early stage adult acquired flatfoot deformity.

Authors:  Youichi Yasui; Ichiro Tonogai; Andrew J Rosenbaum; David M Moore; Masato Takao; Hirotaka Kawano; John G Kennedy
Journal:  Int Orthop       Date:  2016-11-24       Impact factor: 3.075

Review 5.  [Degeneration of the posterior tibial tendon : Established and new concepts].

Authors:  Markus Walther
Journal:  Unfallchirurg       Date:  2017-12       Impact factor: 1.000

6.  Isolated medial column stabilization surgery does not benefit adult acquired flatfoot stage IIa nor IIb by three-dimensional finite element biomechanical analysis.

Authors:  Jian Xu; Abdullah Abdullah; Nedal Alkhatib; Yan Huang; Dawang Xie; Zhiqin Deng; Zhenhan Deng
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

7.  Exercise for posterior tibial tendon dysfunction: a systematic review of randomised clinical trials and clinical guidelines.

Authors:  Megan H Ross; Michelle D Smith; Rebecca Mellor; Bill Vicenzino
Journal:  BMJ Open Sport Exerc Med       Date:  2018-09-19

8.  Prospective Early Clinical, Radiological, and Kinematic Pedobarographic Analysis Following Subtalar Arthroereises for Paediatric Pes Planovalgus.

Authors:  Yvonne-Mary Papamerkouriou; Rohan Rajan; Samena Chaudhry; Preetham Kodumuri; Helen Evans; Martin Kerr
Journal:  Cureus       Date:  2019-12-06

Review 9.  Adult-Acquired Flatfoot Deformity.

Authors:  Jensen K Henry; Rachel Shakked; Scott J Ellis
Journal:  Foot Ankle Orthop       Date:  2019-01-16

Review 10.  The role of arthroereisis of the subtalar joint for flatfoot in children and adults.

Authors:  Alessio Bernasconi; François Lintz; Francesco Sadile
Journal:  EFORT Open Rev       Date:  2017-11-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.